Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06960083 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation in Misophonia
A NA study of Misophonia, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06960083: Recruiting NA study of Misophonia, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06960083 is a NA study of Misophonia that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 60 participants, above the 50-participant average among 7 other Misophonia trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06960083, a NA study of Misophonia, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Participants will perform computerized tasks immediately before and after the stimulation, while EEG, heart rate, and skin temperature will be recorded. These recordings will be used to assess if TMS can be used to improve tolerance to misophonia triggers.
Primary Outcome
Participants will be presented with a slider with extremes labelled as extremely unpleasant and extremely pleasant. Ratings will be provided for audio clips and visual cues. Full scale from 0-100, higher score indicates more unpleasantness
Conditions Studied
Interventions
- OTHER Transcranial Magnetic Stimulation (TMS)
Study Locations (1)
New York
- Mount Sinai West - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06960083 shows while recruiting
NCT06960083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 50-participant average among 7 other Misophonia trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Misophonia appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT06960083 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06960083 about?
NCT06960083 is a clinical study titled "Transcranial Magnetic Stimulation in Misophonia". The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Partic...
What is the current status of trial NCT06960083?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-09-02. Estimated completion is 2026-06-30.
What conditions does trial NCT06960083 study?
This clinical trial studies the following conditions: Misophonia.
What interventions are being tested in trial NCT06960083?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (OTHER).
Who is sponsoring clinical trial NCT06960083?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06960083 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Misophonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
-
Digital Intervention for Adults With Misophonia: A Randomized Controlled Trial
RECRUITING · NA
-
Psychological Intervention for Misophonia
ACTIVE NOT RECRUITING · NA
-
Identifying the Optimal Neural Target for Misophonia Interventions
COMPLETED · NA
-
Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI